Oasmia Pharmaceutical
About:
Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology.
Website: http://www.oasmia.com
Twitter/X: Oasmia
Top Investors: Yorkville Advisors
Description:
Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. The product development is based on in-house research within nanotechnology and company patents.
$37M
Less than $1M
Uppsala, Uppsala Lan, Sweden
1990-01-01
info(AT)oasmia.com
Julian Aleksov
51-100
2019-03-05
Public
© 2025 bioDAO.ai